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Abstract
The assessment of oxidative stress is highly relevant in clinical Perinatology as it is associated to adverse outcomes in
newborn infants. This study summarizes results from the validation of an Ultra Performance Liquid Chromatography–
tandem Mass Spectrometry (UPLC-MS/MS) method for the simultaneous quantification of the urinary concentrations of a set
of endogenous biomarkers, capable to provide a valid snapshot of the oxidative stress status applicable in human clinical
trials, especially in the field of Perinatology. The set of analytes included are phenylalanine (Phe), para-tyrosine (p-Tyr),
ortho-tyrosine (o-Tyr), meta-tyrosine (m-Tyr), 3-NO2-tyrosine (3NO2-Tyr), 3-Cl-tyrosine (3Cl-Tyr), 29-deoxyguanosine (2dG)
and 8-hydroxy-29-deoxyguanosine (8OHdG). Following the FDA-based guidelines, appropriate levels of accuracy and
precision, as well as adequate levels of sensitivity with limits of detection (LODs) in the low nanomolar (nmol/L) range were
confirmed after method validation. The validity of the proposed UPLC-MS/MS method was assessed by analysing urine
samples from a clinical trial in extremely low birth weight (ELBW) infants randomized to be resuscitated with two different
initial inspiratory fractions of oxygen.
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Introduction
Reactive Oxygen Species (ROS) are free radicals and other
chemically reactive molecules formed by partial reduction of
oxygen involved in many physiological processes by modulating
the functionality of redox sensitive proteins in a reversible manner
[1]. ROS can be generated either by endogenous sources such as
the mitochondrial respiratory chain and xanthine and NADPH
oxidases or by exogenous sources such as UV-light, radiation or
xenobiotics [2]. A large number of different ROS are known in
biological systems, the most relevant being superoxide anion
(O2.2), hydrogen peroxide (H2O2), hydroxyl radical (HO), and
peroxynitrite (ONOO2). Excessive amounts of ROS may lead to
oxidative stress defined as a disruption of thiol redox circuits
leading to aberrant cell signaling and dysfunctional redox control
that occurs under normal conditions [3]. ROS mediate oxidative
damage to nucleic acids, lipids, carbohydrates, and proteins.
Under normal circumstances, oxidative damage is counteracted by
enzymatic repair mechanisms. However, under pathologic condi-
tions ROS may induce irreversible oxidation of proteins, nucleic
acids, lipids and carbohydrates leading to further clinical
deterioration [4].
Non-enzymatic phenylalanine (Phe) hydroxylation mediated by
HO. leads to the formation of ortho-tyrosine (o-Tyr) [5,6] and
meta-tyrosine (m-Tyr) isomers [6]. Both, 3-nitrotyrosine (3NO2-
Tyr) and 3-chlorotyrosine (3Cl-Tyr) are oxidized para-tyrosine (p-
Tyr) derivatives formed by peroxynitrite (ONOO2) or hypochlor-
ous acid (HClO), respectively [5]. Altogether, these molecules are
considered reliable biomarkers of oxidative damage to proteins [5–
10]. Besides, 3NO2-Tyr and 3Cl-Tyr are also considered
biomarkers of nitrosative stress, and inflammation and myeloper-
oxidase (MPO) activity, respectively [7–9]. DNA can also be a
target for the action of superoxide anions which may cause
oxidation of both deoxyribose phosphate backbone and the
nucleo-bases. 8-hydroxy-29-deoxyguanosine (8OHdG) (also known
as 8-oxo-29-deoxyguanosine (8-oxodG)), produced by the oxida-
tion of the nucleotide 29-deoxyguanosine (2dG), is commonly used
as biomarker of oxidative damage to DNA [10–13].
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Nevertheless, aerobic organisms have developed antioxidant
defenses capable of effectively scavenge ROS [14]. In the
mammalian newborn placental transfer and fetal synthesis of
antioxidants occurs late in gestation in preparation for transition
into the extra uterine milieu [2,15,16,17]. Especially two
circumstances among others such as prematurity and birth
asphyxia aggravate oxidative stress due to oxygen overload [16–
18]. Hence, it has been shown that resuscitation of term and
preterm infants with high oxygen concentrations causes oxidative
stress [2]. In addition, preterm infants are endowed with an
immature antioxidant defense system which is only partially
responsive to antenatal steroids. Therefore, preterm infants are
extremely sensitive to hyperoxia and prone to develop oxygen free
radical derived conditions that have short- and long-term
consequences in terms of mortality and morbidity [19,20].
Assessment with reliable oxidative stress biomarkers in preterm
infants is therefore becoming a fist line field of research in
Perinatology. In this context the use of urinary oxidative
biomarkers avoiding invasive sampling techniques renders espe-
cially suitable for preterm infants [9,10,21–23]. ILCOR 2010
recommendations for restricting oxygen use in preterm infants
were based on experimental and clinical studies that used urinary
biomarkers to assess oxidative stress [24–26]. In addition, Escobar
et al. [27] recently showed a correlation of o-Tyr, 8OHdG and m-
Tyr with erythropoietin levels in amniotic fluid of pregnant
women with type 1 or insulin-dependent gestational diabetes.
Thus, amniotic fluid oxidative biomarkers may be used in the
future to assess the severity of fetal hypoxia.
A number of procedures for the quantification of Phe, p-Tyr,
halogenated 3Cl-Tyr and 3NO2-Tyr metabolites in urine, mainly
based on gas chromatography (GC) and liquid chromatography
(LC) with mass spectrometric (MS) detection can be found in
literature [7–9]. LC-MS [28–30], LC-electrochemical detection
(LC-ECD) [31] as well as GC-MS [32] have been proposed for the
measurement of 8OHdG in urine. However, analytical methods
targeting newborn infants should be adapted to their very specific
characteristics (e.g. troublesome sample collection, specific con-
centration ranges).
The aim of this study was to develop and validate a rapid, non-
invasive and straightforward UPLC–MS/MS method for the
quantification of eight selected urinary biomarkers (o-Tyr, m-Tyr,
p-Tyr, 3NO2-Tyr, 3Cl-Tyr, Phe, 2dG and 8OHdG) capable of
providing a snapshot of the oxidative stress status of newborns. In
addition, the analysis of a large number of samples from a recent
clinical trial under the acronym REOX [EUDRACT 2088-
005047-42] allowed us to determine the range of urinary
concentrations of these biomarkers in extremely low gestational
age newborns. The REOX trial is a multi-center double-blinded
randomized clinical trial for studying the effects of resuscitation in
ELBW infants initiated with low oxygen concentration (30%)
versus high oxygen (60%) concentration. The objectives of this
clinical trial were to increase the survival rate and reduce the
occurrence of significant morbidities typically observed in prema-
ture infants, such as e.g. severe retinopathy of prematurity and
bronchopulmonary dysplasia. The degree of oxidative stress
experienced during fetal to neonatal transition, reoxygenation
and stabilization has an ample range. However, the selected set of
biomarkers has been capable of detecting significant changes even
under a broad range of pro-oxidant conditions. Moreover, in
order to have a normal pattern of urinary biomarker elimination
the proposed analytes were also quantified using the same UPLC-
MS/MS method in a control group of healthy term newborn
infants born by vaginal delivery and not needing intervention in
the delivery room.
Materials and Methods
Ethics Statement
The study protocol was approved by the local IRB (Institutional
Review Board) of Hospital Universitario y Polite´cnico La Fe
(Valencia; Spain) and also the CEICs (Comite´s de E´tica e
Investigacio´n) of both University Maternity Hospital Casa de
Salud (Valencia; Spain) and Hospital General de Sagunto General
(Valencia; Spain). Parents/guardians of all participating neonates
signed written informed consent.
Solvents and standards
Acetonitrile (LC-MS grade), methanol (LC-MS grade) and
formic acid (analytical grade) were purchased from Sigma Aldrich
Quimica SA (Madrid, Spain). Water was Milli-Q grade
(.18.2 MV) from a Millipore purification system. Standards of
o-Tyr, m-Tyr, Phe, 3NO2-Tyr, 3Cl-Tyr, p-Tyr, 8OHdG and 2dG
(.96% w/w purity) were obtained from Sigma-Aldrich (St. Louis,
MO, USA). Deuterated phenylalanine (Phe-D5) was purchased
from CDN Isotopes (Pointe-Claire, Canada).
Infant’s urine sample collection and pretreatment
Urine samples were obtained from very low birth weight infants
in a randomized and blinded clinical trial carried out in the
Division of Neonatology of Hospital La Fe (Valencia, Spain) which
aimed to compare the safety and efficacy of initiating resuscitation
with lower (30%) versus higher (60%) initial inspiratory fractions of
O2 in the delivery room (REOX, 2012-2013, EUDRACT 2088-
005047-42). Enrolled patients were newly born preterm infants
with a gestational age of , 32 weeks. Twenty-two healthy
newborn term babies with a gestational age of . 37 weeks and
born by spontaneous vaginal delivery were also included in the
study for assessing the suitability of the method in a control group.
Urine samples were obtained by using sterile Hollister collection
bags. Samples were centrifuged, aliquoted and stored at 280uC
until processed. Samples were allowed to thaw on ice to minimize
biological degradation of analytes during the sample preparation
process. Then, they were homogenized by shaking on a Vortex
mixer during 20s and centrifuged at 4uC and 7500 rpm (Biocen 22
R, Orto Alresa, Madrid, Spain) for 10 min to remove large
particles. 100 mL aliquot of supernatants were acidified with 10 mL
of H2O (0.5% v/v formic acid) and 5 mL of 10 mmol/L Phe-D5
internal standard solution were added. For UPLC-MS/MS
analysis, samples were loaded on 96-well plates and analyzed
randomly without having access neither to the physiological
conditions nor to the resuscitation procedure followed for each
patient.
Preparation of stock, working and standard solutions
Individual stock solutions of 8OHdG (1 mM), Phe-D5 (1 mM),
m-Tyr (2 mM), o-Tyr (2 mM), 3NO2-Tyr (2 mM), 3Cl-Tyr
(2 mM), 2dG (2 mM), p-Tyr (10 mM), and Phe (10 mM) were
prepared by accurately weighing the standards and dissolving in
H2O (0.1% v/v HCOOH). Once prepared, each stock solution
was aliquoted and stored at 220uC in capped amber vials. Stock
solutions went through a single freeze and thaw cycle. Working
solutions obtained by dilution of the stock solutions in H2O (0.1%
v/v HCOOH) were used for preparing the standards and for
spiking of samples. Working solutions were kept at 220uC in
capped amber vials and went through a single freeze and thaw
cycle. Standard solutions were prepared by serial dilution of the
working solutions in the concentration intervals summarized in
Table 1. Concentration ranges were selected from concentrations
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found in urine samples during a pre-validation study (results not
shown).
Preparation of spiked samples. A pooled urine sample was
prepared by mixing 250 mL of a total of 14 urine samples collected
from preterm newborns. After homogenization, the pooled sample
was aliquoted and kept at 280uC until its use. Each aliquot went
through a single freeze and thaw cycle. For each validation batch
aliquots of both, pooled urine sample and test samples were
thawed on ice, homogenized by shaking on a Vortex mixer during
20s and centrifuged at 4uC and 7500 rpm for 10 min. 20 mL of
three working solutions of increasing concentrations were added to
200 mL aliquots of supernatant for the preparation of the low,
medium and high level spiked samples. Due to the lack of a blank
urine sample for the recovery assessment, the mean values of basal
levels of the analytes in the pooled sample were used for the
recovery calculations (see Table 2).
UPLC-MS/MS analysis
UPLC-MS/MS analysis was carried out on an Acquity – Xevo
TQ system (Waters, Milford, MA, USA) using positive electro-
spray ionization (ESI) and the following conditions: capillary
0.50 kV, cone 21.00 V, extractor 3.00 V, source temperature 120
uC, desolvation temperature 400 uC, nitrogen cone and desolva-
tion gas flows were 50 and 750 L h21, respectively. Multiple
reaction monitoring (MRM) was carried out using the instrumen-
tal parameters summarized in Table 3. MS parameters (i.e. dwell
time, cone voltage and collision energy) were optimized for each
analyte by analyzing individual standard solutions at a concen-
tration of 500 mmol/L. Dwell time was set to 5 ms to ensure a
minimum of 10 data points per peak. Separation conditions were
selected to achieve appropriate chromatographic retention and
resolution by using an Acquity UPLC BEH C18 reversed phase
column (2.1650 mm, 1.7 mm) (Waters, Milford, MA, USA) and a
CH3OH (0.05% v/v HCOOH):H2O (0.05% v/v HCOOH)
binary gradient. Flow rate, column temperature and injection
volume were set at 0.4 mL min21, 30uC and 5 mL, respectively.
The gradient employed was as follows: from 0 to 1 min 0% v/v
CH3OH (0.05% v/v HCOOH) (i.e. channel B), from 1 to 2.5 min
from 0 to 15% v/v B and from 2.5 to 4.5 from 15 to 99% v/v B.
Conditions were maintained for 0.25 min followed by returning to
initial conditions between 4.5 and 5.1, which were held for
0.9 min for system re-equilibration. During batch analysis,
samples were kept at 4uC in the autosampler. An injection volume
of 5 mL was used.
For Phe, 3Cl-Tyr and p-Tyr two multiple reaction monitoring
(MRM) transitions, one for quantification and the other one for
confirmation, were monitored (see Table 3). Confirmation of the
identity of these analytes in urine samples was based on the
following criteria: i) both UPLC-MS/MS peaks must have the
same retention time; ii) the relative abundance of the MRM signals
at the peak apex must be within 625% of the signal observed in a
standard with a similar concentration; and iii) the MRM
transitions must have signal-to-noise ratios (SNR) higher than 3.
For all other analytes identification was based on the retention
time due to the low intensity of additional MS/MS fragments.
Data was acquired and processed using MassLynx 4.1 and
QuanLynx 4.1 (Waters, Milford, MA, USA), respectively. Linear
response curves were calculated employing Phe-D5 as internal
standard.
Method Validation
The validation of the method was based on the FDA guidelines
for bioanalytical method validation [33] and it was carried out
using a standard operation procedure (SOP) drafted in advance.
The SOP described all the relevant parameters of the method
from sample collection to analysis. The quality parameters (i.e.
Table 1. Figures of merit obtained from the calibration curves used for quantitation.
Analyte Calibration range
Retention Time
(min)a
Concentration range
(LLOQ – ULOQ) R2,b LOD (nM) LOQ (nM)
p-Tyr 0.4 – 200 mM 1.45260.003 0.44 – 220 mM 0.996 39.0 129.9
m-Tyr 16 – 250 nM 1.88960.012 17 – 275 nM 0.996 1.2 3.9
o-Tyr 16 – 1000 nM 2.73360.009 17 – 1100 nM 0.998 2.8 9.5
Phe 0.2 – 200 mM 3.10060.003 0.22 – 220 mM 0.9991 14.4 48.0
3NO2-Tyr 16 – 1000 nM 3.41560.004 17 – 1100 nM 0.995 4.2 14.0
3Cl-Tyr 7 – 2000 nM 3.21160.008 8 – 2200 nM 0.997 0.9 3.0
2dG 7 – 1000 nM 2.5160.02 8 – 1100 nM 0.996 0.7 2.5
8OHdG 2 – 250 nM 3.26360.010 2.2 – 275 nM 0.993 0.2 0.6
a: mean values 6 standard deviation;
b: Regression coefficient for the linear regression curves calculated using (Peak Area Metabolite)/(Peak Area of the Internal standard).as response, and ((Metabolite)/
(Internal standard)) as independent variable. Internal standard: Phe-D5
doi:10.1371/journal.pone.0093703.t001
Table 2. Concentrations of the analytes in the pooled urine
sample.
Analyte Intra-Day (mean±s) Inter-Day (mean±s)
p-Tyr 89.660.4 mM 90 62 mM
m-Tyr 16.660.7 nM 16.560.4 nM
o-Tyr 4961 nM 5469 nM
Phe 37.260.5 mM 3762 mM
3NO2-Tyr ,LOD ,LOD
3Cl-Tyr ,LOD ,LOD
2-dG 76.260.7 nM 7564 nM
8OHdG 5.460.2 nM 661 nM
Note: Intra-day concentrations are the mean (6standard deviation) of three
independent replicate analysis of the pooled sample carried out on the first
validation day. Inter-day mean and standard deviation values were calculated
using the concentrations found in three independent batches of three
independent replicate analysis of the pooled sample
doi:10.1371/journal.pone.0093703.t002
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figures of merit) incorporated in the validation included linearity
range, precision, accuracy, selectivity, limit of detection (LOD) and
quantification (LOQ), dilution integrity as well as sample and
standards stability.
Responses were fit to linear regression with 1/x weighting.
Acceptance criteria for each regression fit were as follows: i)
calibration curves should include at least 6 points excluding the
blank, ii) % relative standard deviations (%RSD) of standard
replicates (n = 3) at three concentrations (i.e. low, mid and high)
should be below 15%, iii) back-calculated accuracy had to be
within 620% of the nominal value and iv) coefficients of
determination (R2) should be higher than 0.99. Nonetheless, as
the use of R2 as linearity test might be misleading, a visual analysis
of the calibration residuals was carried out for evidence of non-
linear behavior [34]. Precision was determined at three levels (i.e.
low, mid and high) in both, standards and spiked samples by
calculating the RSD % of replicates (n = 3) within one validation
batch (intra-day). Accuracy was established by comparing nominal
and observed concentrations in spiked pooled urine samples at the
concentrations summarized in Table 4. The non-spiked pooled
urine sample employed was analyzed by triplicate on each
validation day and results obtained were used for the calculation
of the recovery values. Selectivity was evaluated by analyzing
solvent blanks as well as non-spiked and spiked pooled urine
samples. The LOD and LOQ values were estimated as the
concentrations providing a signal to noise ratio of three and ten.
The accuracy and precision in samples originally above the upper
limit of quantification (ULOQ) was assessed by analyzing spiked
samples at 2.5 times the concentration of the ULOQ following the
above mentioned procedure and after a 1:5 dilution in H2O (0.1%
HCOOH).
Analyte stability after three freeze-thaw cycles and the short-
term stability (i.e. 24h at 4uC) were assessed on a standard solution
and 5 non-spiked samples. Instrument performance was ensured
by analyzing a mid-calibration standard by triplicate at the start of
each validation batch. Carry-over effect between injections was
evaluated by analyzing a blank solution directly after the injection
of the highest concentrated standard.
Analytical quality assurance
An initial system suitability test was carried out at the beginning
of each batch to ensure the following items: i) the backpressure
ripple at the beginning of the chromatographic run was ,3%; ii)
selectivity was ensured at the lower limit of quantification (LLOQ)
for both blank sample (urine sample processed without internal
standard) and a solvent (i.e. H2O (0.05% v/v HCOOH)) injection;
iii) the instrument provided adequate sensitivity and precision
levels. Hence, a standard solution at the lower limit of
quantification (LLOQ) was analyzed by triplicate to ensure that
the %RSD of the peak area values was #25% and the signal to
noise ratios were $15 for each analyte; (iv) retention times did not
vary more than 60.2 min between consecutive batches.
Blank samples and solvent blanks were analyzed at the
beginning of the sample batch measurement, after a high
concentration standard and during the sample batch measurement
to check for potential sources of contamination (e.g. column,
mobile phase additives) and/or cross contamination. A spiked
urine sample was intercalated in the sample batch measurement
and used as quality control (QC) sample to detect deficiencies in
accuracy and precision levels prior to the release of results.
Accordingly, at least 75% of the values found for the QC
standards should be within 625% of their respective nominal
values to accept the batch.
Results
Method validation
The validation of the UPLC-MS/MS method for the quanti-
tative analysis of a subset of oxidative stress urinary biomarkers in
newborns was carried out based on FDA guidelines [33].
Accordingly, the validation parameters included linearity range,
precision, accuracy, selectivity, LOD, LOQ, dilution integrity as
well as sample and standards stability. Additionally carry-over,
retention time stability and instrument precision, were determined
to assess instrument performance.
Figure 1 shows representative UPLC-MS/MS chromatograms
used for quantification extracted from the analysis of a spiked
pooled urine sample. The main figures of merit obtained from the
calibration curves including the concentration ranges of standards
are summarized in Table 1. Retention time was found to be highly
stable during the whole validation study with an intra-day
standard deviation of the retention time of ,0.02 min. Besides,
no interfering peaks were observed from the comparison of
UPLC-MS/MS chromatograms of blanks, non-spiked and spiked
urine samples. System suitability was ensured by analyzing a
middle calibration standard by triplicate at the start of each
validation batch providing in all cases responses with RSD%
values below 15%. The carry-over effect of the auto sampler was
evaluated at the start of each validation batch by analyzing a blank
Table 3. MS/MS acquisition parameters.
m/z daughter ion
Analyte m/z parent ion Cone (V) Quantification CE (eV) Confirmation CE (eV)
p-Tyr 182.1 30 136.1 15 119.2 15
m-Tyr 182.1 30 136.1 15 - -
o-Tyr 182.1 30 136.1 15 - -
Phe 166.1 25 120.1 15 103.1 15
3NO2-Tyr 227.1 25 181.2 15 - -
3Cl-Tyr 216.1 25 170.1 15 157.1 15
2dG 268.0 15 152.0 10 - -
8OHdG 284.1 20 168.1 15 - -
Phe-D5 171.1 35 125.0 10 - -
doi:10.1371/journal.pone.0093703.t003
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injection directly after the injection of the highest concentrated
standard. Results obtained showed that, for all MRMs included in
the UPLC-MS/MS method, responses were lower than 5% of the
lower LOQ (LLOQ) standard response, thus confirming the lack
of a carry-over effect. As shown in Table 1, linear curves were
calculated including a number of standards ranging between 6 and
12 for the different analytes. Both, the obtained coefficients of
determination (R2$0.993) and the homoscedasticity of the
residuals (results not shown) were consistent with pre-established
criteria, thus indicating appropriate linear responses in the selected
concentration intervals. LODs for the measurement of protein and
DNA oxidation products were ranging between 0.2 and 4.2 nmol/
L. Precision and back-calculated accuracies obtained for standards
at three concentration levels are summarized in Table 4.
Recoveries were within 620% deviation from the nominal value
thus complying with the acceptability requirements. Precision
values were also within the acceptability range indicating a high
repeatability of the method. Table 4 summarizes the accuracy and
precision values obtained from the analysis of spiked urine samples
at three concentration levels (low, medium and high). As shown in
this table, accuracy and precision levels of o-Tyr, m-Tyr, p-Tyr,
Phe, 3NO2-Tyr, 3Cl-Tyr and 2dG fulfilled the pre-defined
acceptance criteria. On the other hand, recoveries for 8OHdG
at the low level were below the acceptability threshold ($80%).
A dilution integrity test was carried out to assess the accuracy of
the method in those samples in which the analytes were above the
upper limit of quantification and needed to be diluted. Accord-
ingly, three replicated spiked pooled urine samples were prepared
to reach concentration levels 2.5 times above the upper LOQ
(ULOQ). Then, the samples were diluted 5 times and analyzed.
The back calculated concentrations of the oxidative stress
biomarkers were within 75–117% of their nominal concentration
with %RSD values ranging between 0.8 and 4%.
On storage at ‘auto sampler conditions’ (i.e. 24 h at 4uC), the
concentration of the analytes from a mid-concentration standard
was in the 9762% range with respect to a freshly prepared
standard. Again, no statistically significant differences were
observed in the recovered concentrations of the analytes in both,
standards and spiked samples after three freeze and thaw cycles,
with deviations in their concentrations below 4%.
Analysis of urine samples of extremely low birth-weight
infants
Samples collected in a clinical assay aiming to reduce the
oxygen load for preterm babies during postnatal resuscitation
[REOX, 2012–2013, EUDRACT 2088-005047-42] were ana-
lyzed following the proposed procedure with a double objective: i)
the assessment of the performance of the method for the analysis of
real samples, and ii) the identification of reference concentration
ranges for the selected metabolites in urine samples from preterm
newborns.
Figure 2 displays box plots of non-zero concentrations found
from the analysis of 222 urine samples of extremely low birth-
weight infants included in the REOX clinical study [EUDRACT
2088-005047-42]. The percentages of concentrations,LOD in
the sample set were: 0.4% for 8OH-dG; 0.4% for 2dG; 93% for
NO2-Tyr; 68% for 3Cl-Tyr; 15% for o-Tyr; 79% for m-Tyr, and
0% for p-Tyr and Phe. All detected concentrations were within the
calibration ranges, not requiring reanalysis after sample dilution.
Due to existing difficulties regarding normalization of the absolute
concentrations of the analytes among different individuals, the
ratio of the oxidation products and their precursors are typically
reported, facilitating the biological interpretation of the figures.
Figure 3 shows boxplots of ratios of o-Tyr/Phe, m-Tyr/Phe, 3Cl-
Tyr/p-Tyr, 3NO2-Tyr/p-Tyr and 8OHdG/2dG found for the set
of urine samples included in the clinical study.
Analysis of urine samples of healthy term newborns
Urine samples of healthy breastfed term newborn babies
(gestational age 37 to 40 weeks’ gestation) born by vaginal delivery
without instrumentation after uncomplicated gestation and with
normal Apgar score at 1 and 5 min after birth at the University
and Politechnic Hospital La Fe (Valencia; Spain), University
maternity Hospital Casa de Salud (Valencia; Spain) and Hospital
General de Sagunto (Valencia; Spain) were collected and analyzed
following the proposed procedure to establish reference basal
urinary ranges for the selected biomarkers. Table 5 lays out the
range, median and mean values for the concentration of the
selected biomarkers in the control group as well as the
corresponding o-Tyr/Phe, 3NO2-Tyr/p-Tyr and 8OHdG/2dG
ratios. The urinary concentrations of m-Tyr in the control group
were lower than the LOD and therefore it was not possible to
calculate the 3Cl-Tyr/p-Tyr ratio for healthy term newborns.
Table 4. Back calculated accuracy and precision levels of calibration standards and spiked samples during the validation.
Analyte Calibration standards Recovery ±s (concentration) Spiked samples Recovery ±s (spiked concentration)
a
Low Medium High Low Medium High
p-Tyr 12264 (0.8 mM) 8664 (12.5 mM) 9561 (150 mM) 9065 (110 mM) 11163 (140 mM) 12362 (170 mM)
m-Tyr 9866 (31 nM) 10065 (125 nM) 98.960.6 (188 nM) 8661.6 (80 nM) 90.060.5 (130 nM) 9763 (200 nM)
o-Tyr 10369 (31 nM) 9563 (250 nM) 9963 (750 nM) 9664 (200 nM) 100.260.5 (475 nM) 100.760.8 (725 nM)
Phe 10964 (0.4 mM) 10062 (12.5 mM) 9961 (150 mM) 9862 (60 mM) 100.660.2 (115 mM) 100.860.7 (170 mM)
3NO2-Tyr 10469 (31 nM) 9367 (250 nM) 9863 (750 nM) 7764 (180 nM) 9365 (455 nM) 91.660.3 (725 nM)
3Cl-Tyr 10766 (16 nM) 8963 (250 nM) 9963 (1500 nM) 99.861.5 (180 nM) 100.360.8 (910 nM) 101.060.9 (1600 nM)
2-dG 10968 (16 nM) 8865 (125 nM) 9.70 9862 (750 nM) 9961 (250 nM) 10361 (530 nM) 10162 (725 nM)
8OHdG 106610 (4 nM) 8868 (31 nM) 9863 (188 nM) 6763 (80 nM) 8162 (120 nM) 8166 (190 nM)
a: concentrations in the spiked samples were calculated after subtracting the mean levels (n = 3) measured in the non-spiked pooled urine samples during each
validation batch.
doi:10.1371/journal.pone.0093703.t004
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Discussion
Newborn infants, especially preterm infants, are prone to
oxidative stress related diseases, which unequivocally influence
their mortality, morbidity and long-term outcomes [20,35]. Urine
analysis has been considered to be a suitable alternative to e.g.
invasive blood-based procedures. Besides, protein content in urine
is lower and therefore sample preparation for LC-MS analysis is
simpler than that needed for other bio-fluids (e.g. serum or plasma)
[36].
The UPLC-MS/MS method for the quantification of eight
selected urinary biomarkers (o-Tyr, m-Tyr, p-Tyr, 3NO2-Tyr,
3Cl-Tyr, Phe, 2dG and 8OHdG) was validated following FDA
guidelines for bioanalytical method validation [33]. However, the
FDA guideline aims at the analysis of drugs and their metabolites
in a biological matrix and it cannot be fully applied to the analysis
of endogenous metabolites. Whereas the guideline recommends
the preparation of the calibration curve in the same biological
matrix as the samples by spiking the matrix with known
concentrations of the analytes, in this study the standards were
prepared in H2O (0.05% HCOOH) due to the lack of suitable
blank matrices. However, the assessment of the main figures of
merit of the method including linearity range, precision, accuracy,
selectivity, LOD and LOQ, dilution integrity as well as sample and
standards stability, provided satisfactory results.
Representative chromatograms depicted in Figure 1 from the
analysis of a spiked pooled urine sample, showed adequate
selectivity and resolution among the analytes. Linear response was
assessed in the selected concentration intervals with LODs in the
nmol/L range ensuring a broad applicability of the method and a
Figure 1. Typical chromatograms of the selected biomarkers extracted from the analysis of spiked urine sample. Note: Spiking
concentrations were 73 nmol/L for 8OhdG and m-Tyr, 182 nmol/L for 2-dG, o-Tyr, 3NO2-Tyr and 3Cl-Tyr and 23 mM for p-Tyr and Phe.
doi:10.1371/journal.pone.0093703.g001
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high repeatability of the retention times facilitating reliable analyte
identification (see Table 1). Calculated concentrations of protein
and DNA oxidation products from the analysis of spiked urine
sample at three levels showed adequate precision and back-
calculated accuracies. Recovery values were within 620%
deviation from the nominal value with the exception of 8OHdG
at the low level (6763%). Besides, dilution integrity test provided
back accuracies in the 75–117% range with %RSD values ranging
Figure 2. Non-zero concentrations found from the analysis of 222 urine samples of extremely low birth-weight infants included in
the double-blinded randomized clinical study REOX (REOX 2012-2013, EUDRACT 2088-005047-42). The percentages of
concentrations,LOD in the sample set were: 15% for o-Tyr, 79% for m-Tyr, 0% for p-Tyr and Phe, 93% for NO2-Tyr, 68% for 3Cl-Tyr, 0.4% for
8OH-dG and 0.4% for 2dG. Boxes indicate the 1st and the 3rd quartiles, the median is shown as a black line, whiskers mark the 9th and 91st percentiles,
red triangles represent mean concentrations and blue circles are outliers.
doi:10.1371/journal.pone.0093703.g002
Figure 3. Boxplots of the ratios of o-Tyr/Phe, m-Tyr/Phe, 3NO2-Tyr/p-Tyr, 3Cl-Tyr/p-Tyr and 8OHdG/2dG for the set of non-zero
urine samples included in the REOX clinical study. Boxes indicate the 1st and the 3rd quartiles, the median is shown as a black line, whiskers
mark the 9th and 91st percentiles, red triangles represent mean concentrations and blue circles are outliers.
doi:10.1371/journal.pone.0093703.g003
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between 0.8 and 4%. These results ensured the applicability of the
method in samples in which concentrations of the target analytes
are up to 2.5 times above the upper LOQ (ULOQ), thus
increasing its applicability. The stability of the analytes at ‘auto
sampler conditions’ (i.e. 24 h at 4uC) was confirmed as the
observed variation in the response of the analytes was within the
range attributed to the instrumental imprecision. Besides, analyte
concentrations were found to be stable in both, standards and
spiked samples after three freeze and thaw cycles, with deviations
in the concentrations below 4% facilitating the sample collection
and storage before analysis. From results found it could be
concluded that this method outperforms a previous HPLC-MS
based approach for the assessment of oxidative damage to proteins
and DNA in urine as it fulfills specific requirements related to
sample collection in preterm infants, and it combines an easy and
quick sample preparation for the simultaneous determination of a
set of metabolites capable to provide a snapshot of the oxidative
status of the newborn.
The analytical approach, covering from sample collection to
sample analysis, was successfully evaluated in a clinical study
involving a total of over 200 urine samples from extremely low
birth-weight infants previously described (see Introduction) [EU-
DRACT 2088-005047-42]. The high number of samples allowed
to establish a set of reference ranges for o-Tyr, m-Tyr, p-Tyr,
3NO2-Tyr, 3Cl-Tyr, Phe, 2dG and 8OHdG concentrations in
ELBW infants. In addition, we have also applied our method to
healthy newborn patients to test its suitability and to establish the
basal levels of the selected biomarkers in a control group.
Interestingly, we were able to detect and quantify Basal levels of
Phe, p-Tyr, o-Tyr, 3NO2-Tyr, 3Cl-Tyr and 8OHdG were
determined. In contrast, basal levels of m-Tyr were below the
LOD. Nonetheless, minimal values for m-Tyr in the urine samples
of the preterm babies were respectively 5 times higher than the
LOQs and 10 to 15 times higher than the LODs indicating that
the sensitivity of the method was appropriate. The analysis of a
larger cohort of healthy term babies is necessary to increase the
robustness of the reference basal intervals, and will help to evaluate
the need for higher preconcentration factors for the quantification
of m-Tyr at basal levels. Further research will be carried out to
assess the potential use of the panel of metabolites to establish an
association between the type of treatment and the level of
oxidative stress in the newborn. We hope that current efforts on
the field will serve to define evidence-based recommendations for
establishing optimal oxygen use during the resuscitation of preterm
infants.
Whereas the method was specifically developed for the analysis
of biomarkers of oxidative stress in urine samples from newborns it
could be easily adapted to study responses related to oxidative
stress in other fields such as the study of the effect of radio- and/or
chemotherapy in cancer patients, or the evaluation of changes in
the overall oxidative status upon nutritional interventions.
Therefore, this method would have an impact on ongoing
research aiming at a better understanding of the pathogenic
mechanisms of disease or at improving predictions of the onset and
disease progressions in newborns and especially preterm infants
[37].
Conclusions
This paper reports the validation of a novel, fast and
straightforward UPLC-MS/MS method for the simultaneous
quantification of a set of oxidative stress biomarkers formed by
six protein and DNA oxidation products and three precursors,
including o-Tyr, m-Tyr, p-Tyr, 3NO2-Tyr, 3Cl-Tyr, Phe, 2dG
and 8OHdG in urine samples from newborns. Urinary concen-
tration of these biomarkers provides highly reliable information on
the oxidative status of these patients in the 12–24 hours previous
to urine collection given the low glomerular filtration rate of
preterm infants [38]. The method involves a single pretreatment
step thus facilitating its application in clinical studies. In addition,
the reduced sample volume required has rendered this method
extraordinarily suitable for the assessment of the oxidation status
in the highly vulnerable premature infants. This method could
contribute to generate consistent results among different labora-
tories, which may in turn facilitate gaining insight into the effect of
oxidative stress in both preterm and term infants.
Table 5. Results control group (n = 6) consisting of term newborn infants born by vaginal delivery and lacking perinatal
complications.
Range Median Mean ± s % Zero Samples p-Value
p-Tyr (mM) 9.8-464.6 71.1 105 6 111.9 0 0.2
m-Tyr (nM) - - - 100 ,0.001
o-Tyr (nM) 12.4-92 29.1 40 6 24.7 0 ,0.001
Phe (mM) 9.2–68.6 32.6 35.1 6 19.3 0 0.4
3NO2Tyr (nM) 1.7–9.9 3.3 4.2 6 2.5 82 0.4
3Cl-Tyr (nM) 5.1–14.5 10.3 10.1 6 4.6 91 ,0.001
2dG (nM) 18–422.8 84.4 133.1 6 123.3 0 0.06
8OHdG (nM) 1.7–37.9 8.5 10.7 6 8.1 0 0.14
m-Tyr/Phe - - - 100 ,0.001
o-Tyr/Phe 1.9*10-4 – 2*1023 1.3*1023 1.3*1023 6 5*1024 0 ,0.001
3NO2Tyr/p-Tyr 4*10
26 – 9*1025 2*1025 3*1025 6 3*1025 82 0.003
3Cl-Tyr/p-Tyr 9*1025–1.3*1024 1*1024 1.1*1024 6 1.3*1025 91 ,0.001
8OHdG/2dG 0.014–0.5 0.1 0.12 6 0.08 0 0.15
Note: p-values correspond to two-groups (i.e. control vs extremely low birth-weight infants included in the study) comparisons using Student’s t-test for independent
data and assuming unequal variances. m-Tyr has not been detected in any sample.
doi:10.1371/journal.pone.0093703.t005
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